Form 4 for EFX Equifax
Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-10 · accession 0001225208-23-001892 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-14 | 2023-02-10 | EFX | Nelson Lisa M | EVP, Pres International | A - Grant | $0.00 | +2,426 | 9,838 | +33% | $0 |
| D | 2023-02-14 | 2023-02-10 | EFX | Nelson Lisa M | EVP, Pres International | A - Grant | $0.00 | +7,730 | 7,730 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-10 | A | A | 2,426 | $0.00 | 9,838 | D | — | — | (F1) Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 10, 2026. (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 2 | Derivative | Stock Option/Right to Buy | 2023-02-10 | A | A | 7,730 | $0.00 | 7,730 | D | $206.16 · — to 2033-02-10 | 7,730 Common Stock | (F3) Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 10, 2024. |